Literature DB >> 26411393

Identifying Patient-Specific Pathology in Osteoarthritis Development Based on MicroCT Analysis of Subchondral Trabecular Bone.

Marla J Steinbeck1, Peter T Eisenhauer2, Mitchell G Maltenfort3, Javad Parvizi3, Theresa A Freeman2.   

Abstract

The goal of this study was to identify alternative mechanisms of osteoarthritis pathology by analyzing subchondral bone. Femoral condyle samples were collected from post-menopausal female patients with knee osteoarthritis undegoing total knee arthroplasty. In the majority of patients, subchondral trabecular bone volume doubled under a region of the medial femoral condyle with full-thickness cartilage deterioration. However, in a subset of patients the bone volume in this region remained constant. This subset also had larger areas of vascular penetration in the calcified cartilage of the lateral condyle concurrent with increased vascular endothelial growth factor expression. Subtyping by subchondral bone characteristics identified a unique population, which lacked the sclerotic bone characteristic of late-stage osteoarthritis. Identification of subtypes within the osteoarthritis population allows investigation of alternate disease pathologies.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  VEGF; microCT; osteoarthritis; osteoclasts; subchondral bone

Mesh:

Substances:

Year:  2015        PMID: 26411393     DOI: 10.1016/j.arth.2015.08.021

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  2 in total

Review 1.  Is osteoarthritis one disease or a collection of many?

Authors:  Leticia A Deveza; Richard F Loeser
Journal:  Rheumatology (Oxford)       Date:  2018-05-01       Impact factor: 7.580

2.  Decreased trabecular bone deterioration of proximal tibiae and lumbar vertebrae in postmenopausal women with osteoarthritis.

Authors:  Zhenhua Yin; Wei Wang; Jian Han; Ke Chen; Jianjun Ma
Journal:  Exp Ther Med       Date:  2017-05-08       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.